Plain-English translation of NCT05994170 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This is a large study comparing two different ways of planning radiation therapy for people with newly diagnosed nasopharyngeal cancer. Researchers want to know whether reducing the size of the radiation treatment area โ by targeting only the tumor itself plus a small margin โ works just as well as the traditional approach of treating the tumor, a margin around it, and the entire nasopharynx (the upper part of the throat behind the nose).
Radiation therapy can damage healthy tissue, cause side effects, and affect quality of life. Doctors believe that smaller, more precise treatment areas might control the cancer equally well while reducing harm to nearby healthy tissues and reducing long-term side effects like pain or difficulty swallowing.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will be randomly assigned to receive radiation therapy with either a smaller treatment area (tumor plus a 5mm margin) or a larger treatment area (tumor plus margin plus the entire nasopharynx). You will also receive chemotherapy based on your cancer stage, as recommended by standard guidelines. The study will follow you for years afterward, tracking how well the cancer is controlled, your survival, and any side effects from the radiation therapy.
AI-generated summary from trial data ยท Jun 13, 2026 ยท Not medical advice
China
Sponsor
Zhongshan People's Hospital, Guangdong, China
Collaborators
Sun Yat-Sen University Cancer Center
Enrollment target
~454 participants
Started
August 2023
Primary completion
August 2026
Age range
18 Years โ 70 Years
Last updated on clinicaltrials.gov in August 2023.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Gui-qiong Xu
Zhongshan People's Hospital, Guangdong, China
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.